Mount Logan Capital Inc operates as emerging asset management and investment firm focused on investing in public and private debt securities in the North American market... Show more
Industry InvestmentManagers
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| RZV | 140.28 | 1.50 | +1.08% |
| Invesco S&P Smallcap 600 Pure Value ETF (RZV) | |||
| BRIB | 24.15 | 0.05 | +0.21% |
| FIS Bright Portfolios Core Bond ETF (BRIB) | |||
| UXOC | 40.02 | 0.02 | +0.04% |
| FT Vest U.S. Equity Uncapped Accelerator ETF - October (UXOC) | |||
| KTN | 25.64 | -0.03 | -0.11% |
| Structured Products CorTS Aon Capital A | |||
| BMEZ | 16.58 | -0.12 | -0.72% |
| BlackRock Health Sciences Term Trust | |||
A.I.dvisor indicates that over the last year, MLCI has been loosely correlated with HSDT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if MLCI jumps, then HSDT could also see price increases.
| Ticker / NAME | Correlation To MLCI | 1D Price Change % | ||
|---|---|---|---|---|
| MLCI | 100% | -1.47% | ||
| HSDT - MLCI | 60% Loosely correlated | N/A | ||
| GCMG - MLCI | 29% Poorly correlated | +1.47% | ||
| HLNE - MLCI | 28% Poorly correlated | +1.97% | ||
| TPG - MLCI | 27% Poorly correlated | +1.36% | ||
| CRBG - MLCI | 25% Poorly correlated | +1.63% | ||
More | ||||
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MLCI advanced for three days, in 24 of 39 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
The Momentum Indicator moved above the 0 level on September 22, 2026. You may want to consider a long position or call options on MLCI as a result. In 11 of 28 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 39%.
The Moving Average Convergence Divergence (MACD) for MLCI just turned positive on September 23, 2026. Looking at past instances where MLCI's MACD turned positive, the stock continued to rise in 5 of 17 cases over the following month. The odds of a continued upward trend are 29%.
MLCI moved above its 50-day moving average on September 22, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MLCI crossed bullishly above the 50-day moving average on August 27, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 1 of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 10%.
The Aroon Indicator entered an Uptrend today. In 18 of 47 cases where MLCI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 38%.
The 10-day RSI Indicator for MLCI moved out of overbought territory on September 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 7 similar instances where the indicator moved out of overbought territory. In 1 of the 7 cases, the stock moved lower in the following days. This puts the odds of a move lower at 14%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 11 of 20 cases where MLCI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 55%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MLCI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
MLCI broke above its upper Bollinger Band on September 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 10 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.656) is normal, around the industry mean (3.242). P/E Ratio (1.137) is within average values for comparable stocks, (26.802). Projected Growth (PEG Ratio) (0.350) is also within normal values, averaging (1.341). Dividend Yield (0.034) settles around the average of (0.081) among similar stocks. P/S Ratio (0.367) is also within normal values, averaging (15.853).
The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating fairly steady price growth. MLCI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 62 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 94 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MLCI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.